Silence Therapeutics plc (SLN) Gross margin 2022–2025
Silence Therapeutics plc (SLN) gross margin by fiscal year — reported gross profit divided by reported revenue.
61.5%FY2025 · since FY2022: 37.8% → 61.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 61.5% | -11.2 pp |
| FY2024 | 72.7% | +13.4 pp |
| FY2023 | 59.3% | +21.5 pp |
| FY2022 | 37.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice